Tag: vaping investigation

  • Cannabis Company Raided Over Illegal Vape Cartridge Allegations

    Cannabis Company Raided Over Illegal Vape Cartridge Allegations

    Kushy Punch was served with a search warrant after a police investigation turned up unauthorized marijuana products at a dispensary.

    California state and law enforcement officials raided a factory owned by a manufacturer of cannabis products after allegations surfaced that the company was making illegal vape products.

    Kushy Punch, which makes edibles, tinctures and vape cartridges, was served with a search warrant at one of its two Southern California-based manufacturing facilities after a police investigation turned up unauthorized marijuana products at a dispensary.

    Expired Batteries

    The products were linked back to Kushy, where the same disposable vape cartridges, which contained expired batteries, were found during the search; legal counsel for the company said that the items were intended to be destroyed, and intends to work closely with state officials to product customers.

    The news of the search warrant at Kushy raised concerns over the wave of health problems linked to vaping marijuana products that have sickened more than 1,500 individuals across the United States and claimed the lives of at least 30 people.

    As both the Centers for Disease Control and the Food and Drug Administration have noted, no single substance or product has been shown to be the direct cause for the illnesses, but investigations have found that some unlicensed sources have produced “bootleg” vaping cartridges that have contained pesticides, heavy metals and vitamin E acetate, all of which can cause serious respiratory problems.

    Cannabis Safety Team Conducts Investigation, Finds “Discrepancies”

    In the case of Kushy, the California Bureau of Cannabis Control (BCC) conducted an investigation into reports that the company was manufacturing illegal vape cartridges and edibles and distributing them to dispensaries. The bureau’s Cannabis Safety Team then conducted an inspection of a dispensary in Hollister, where Kushy products had been on sale until management pulled them over concerns about the investigation.

    Police from Hollister and the safety team reviewed testing paperwork provided by Kushy and found what were described on San Benito as “discrepancies” between the test results and Kushy’s packaging. This sent the BCC and the Department of Consumer Affairs’ Cannabis Enforcement Unit to Kushy’s factory in Canoga Park, California, where a search warrant led to the seizure of approximately $21 million in illegal cannabis products, including 7,200 vape cartridges.

    According to Marijuana Business Daily, the state regards Kushy as an illegal business, a status which is disputed by the company, which maintains that it has a license with the California Department of Public Health, and passed all BCC inspections as of October 3.

    Eric Shevin, legal counsel for Kushy Punch, told Marijuana Business Daily in a statement that the cartridges confiscated by the BCC were “located in a single box labeled for destruction following their discovery among packaging and marketing materials at a separate storage facility. These cartridges were unusable due to their age, as their batteries had died after being stored for more than two years.”

    Shevin added that the company “intends to cooperate and work closely with the BCC in its efforts to protect consumers and license holders.” A spokesperson for the BBC declined to comment on the issue beyond noting that the investigation was ongoing.

    View the original article at thefix.com

  • FDA, DEA Partner For Probe Into Vaping Illnesses

    FDA, DEA Partner For Probe Into Vaping Illnesses

    The agencies are focusing on vaping manufacturers in order to “[follow] the supply chain to its source.”

    The Drug Enforcement Administration (DEA) will assist the Food and Drug Administration (FDA) in its investigation into the spate of vaping-related illnesses that have sickened more than 1,000 and claimed at least 18 lives.

    In testimony before a House Energy and Commerce subcommittee on September 25, acting FDA Commissioner Dr. Ned Sharpless said that the agencies will collaborate to determine “if someone is manufacturing or distributing illicit, adulterated products that caused illness or death for personal profit,” which would be considered a criminal act.

    FDA Waited Too Long To Review Vaping Products

    Sharpless acknowledged that the FDA should not have waited to review e-cigarette products, a decision which some lawmakers have said was a contributing factor in the rise of teen e-cigarette use.

    Sharpless’s testimony came on the heels of the FDA’s announcement of a criminal problem into the rash of vaping illnesses, which they announced on September 19. He mentioned that the decision to bring the DEA into the probe is due to the number of illnesses and deaths related to the use of vaping cartridges containing THC.

    As for the focus of the probe, Sharpless said that the agencies are focusing on vaping manufacturers in order to “[follow] the supply chain to its source.”

    Additionally, Sharpless said that the FDA plans to finalize a draft of new guidance for flavored vaping products. Warning letters will be sent to manufacturers that do not remove those products—save for those that are flavored like tobacco—from the market. Those that do not comply may be subjected to additional warning letters, as well as possible fines and injunctions.

    Why Did The FDA Take So Long to Act?

    But lawmakers on the subcommittee also wanted to know why the agency appeared to wait nearly three years in order to take action in regard to e-cigarettes.

    The FDA asked companies in 2016 to file applications to market products by August of 2018, but as STAT News noted, former FDA Commissioner Scott Gottlieb shifted the agency’s focus to curbing nicotine levels in traditional cigarettes, while also delaying the marketing applications to 2022 (the deadline has since been moved to May 2020).

    In response to the subcommittee’s inquiries, Sharpless said that the “FDA should’ve acted sooner,” but added that the probe, and the addition of the DEA to its efforts, should help them “catch up.”

    “We will not rest until we have answers to the questions in the investigation, and until we have dramatically reduced the access and appeal of e-cigarettes to kids,” he said.

    View the original article at thefix.com